SPICA THERAPEUTICS

Antwerpen ·KBO/BCE: BE 1012.800.853

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	82.6%	49.8%	better than 80% of 81 sector peers
Net result	€-2.73M	€17k	better than 5% of 80 sector peers
Equity	€6.16M	€102k	better than 93% of 81 sector peers
Gross operating margin	€-1.01M	€49k	better than 5% of 76 sector peers
Total assets	€7.45M	€250k	better than 92% of 81 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€7.45M
Fixed assets	21/28	€4.99M
Intangible fixed assets	21	€96k
Tangible fixed assets	22/27	€7k
Financial fixed assets	28	€4.88M
Current assets	29/58	€2.47M
Amounts receivable within one year	40/41	€1.13M
Cash & bank	54/58	€997k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€7.45M
Equity	10/15	€6.16M
Contributions / capital	10/11	€8.89M
Accumulated profits (losses)	14	€-2.73M
Amounts payable	17/49	€1.30M
Amounts payable within one year	42/48	€1.16M
Trade debts payable within one year	44	€1.15M
Income statement
Gross operating margin	9900	€-1.01M
Operating result	9901	€-2.79M
Financial charges	65	€4k
Result before taxes	9903	€-2.79M
Income taxes	67/77	€-59k
Net result for the period	9904	€-2.73M
Result to be appropriated	9905	€-2.73M

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	26-08-2024
Status	Active
Postal code	2600

Summary